First Trust Advisors LP Neogenomics Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Neogenomics Inc stock. As of the latest transaction made, First Trust Advisors LP holds 31,705 shares of NEO stock, worth $475,892. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,705

Previous 87,533 63.78%

Holding current value

$475,892

Previous $1.21 Million 61.53%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.4 - $17.73 $748,095 - $989,830	-55,828 Reduced 63.78%	31,705 $467,000
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $1.43 Million - $1.73 Million	-109,997 Reduced 55.69%	87,533 $1.21 Million
Q1 2024 May 13, 2024	BUY	$14.06 - $16.79 $1.98 Million - $2.37 Million	140,903 Added 248.83%	197,530 $3.11 Million
Q4 2023 Feb 13, 2024	BUY	$11.67 - $20.73 $660,837 - $1.17 Million	56,627 New	56,627 $916,000
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $487,842 - $1.04 Million	53,668 New	53,668 $934,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $450,244 - $739,523	57,283 Added 59.57%	153,441 $1.32 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $13.97 $678,875 - $1.34 Million	96,158 New	96,158 $784,000
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $574,257 - $1.67 Million	-47,264 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$30.49 - $48.49 $1.44 Million - $2.29 Million	47,264 New	47,264 $1.61 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $594,779 - $749,828	-14,277 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $3.12 Million - $4.4 Million	-85,168 Reduced 85.64%	14,277 $645,000
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $283,272 - $408,142	-6,816 Reduced 6.41%	99,445 $4.8 Million
Q4 2020 Feb 02, 2021	BUY	$36.08 - $56.47 $426,176 - $667,023	11,812 Added 12.51%	106,261 $5.72 Million
Q3 2020 Nov 05, 2020	SELL	$33.26 - $40.48 $1.29 Million - $1.57 Million	-38,860 Reduced 29.15%	94,449 $3.48 Million
Q2 2020 Jul 22, 2020	BUY	$24.21 - $31.02 $822,002 - $1.05 Million	33,953 Added 34.17%	133,309 $4.13 Million
Q1 2020 May 06, 2020	BUY	$20.5 - $34.53 $1.33 Million - $2.24 Million	65,003 Added 189.22%	99,356 $2.74 Million
Q4 2019 Feb 03, 2020	SELL	$18.96 - $29.84 $1.62 Million - $2.55 Million	-85,506 Reduced 71.34%	34,353 $1.01 Million
Q3 2019 Nov 04, 2019	SELL	$19.12 - $26.24 $1.07 Million - $1.46 Million	-55,777 Reduced 31.76%	119,859 $2.29 Million
Q2 2019 Jul 30, 2019	BUY	$19.57 - $24.1 $667,023 - $821,424	34,084 Added 24.08%	175,636 $3.85 Million
Q1 2019 May 09, 2019	SELL	$12.14 - $20.46 $546,421 - $920,904	-45,010 Reduced 24.13%	141,552 $2.9 Million
Q4 2018 Feb 07, 2019	BUY	$11.24 - $18.5 $2.1 Million - $3.45 Million	186,562 New	186,562 $2.35 Million

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.89B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Neogenomics Inc Transaction History